Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AVX Pharma

AVX Pharma
2013 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$29.2K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of medicinal drugs designed to offer treatment for ophthalmic diseases. The company's drugs focuses on ocular surface diseases by providing advanced medicinal products, enabling patients to recover faster from dry eye syndrome.

Formerly Known As
Avizorex Pharma
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Parc Científic de Barcelona
  • C/Baldiri Reixac 4-8, Torre R
  • 08028 Barcelona
  • Spain
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AVX Pharma’s full profile, request a free trial.

AVX Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant $29.2K 00.000 Completed Clinical Trials - General
2. Accelerator/Incubator 19-Jun-2017 000.00 00.000 Completed Clinical Trials - General
1. Early Stage VC (Series A) 27-Oct-2014 $3.17M $3.17M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AVX Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
EIT Health Government Minority 000 0000 000000 0
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0
Empresa Nacional de Innovación Venture Capital Minority 000 0000 000000 0

AVX Pharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Patrick Tresserras Co-Founder, President, Chief Executive Officer & Board Member
Jordi Petit Salamo Chief Financial Officer
Carlos Belmonte Ph.D Co-Founder

AVX Pharma Board Members (3)

Name Representing Role Since Contact
Info
Patrick Tresserras AVX Pharma Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Roger Piqué Pijuan Inveready Technology Investment Group Board Member 000 0000
Sara Secall Inveready Technology Investment Group Board Member 000 0000